Product Pipeline

Pipeline

Oncothyreon is developing small molecules and therapeutic vaccines, increasing our opportunities to improve the lives and outcomes for cancer patients.
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >

Pipeline

Oncothyreon's pipeline of innovative product candidates includes small molecule compounds and immunotherapies that target diverse aspects of cancer. Developing candidates with distinct mechanisms of action enhances our ability to provide clinical benefit across multiple cancer indications.

tecemotide ont-380 ont-10 pet-lipid a non-small cell lung cancer hers2+ breast cancer
Our Pipeline Targets Large Cancer Indications
Read More >
Dedicated to Improving the Treatment of Cancer
Read More >